Clinical Trial

Real-world Study of StimLabs Human Placental Membrane Tissue to Treat Hard-to-Heal Wounds

Completed
View on ClinicalTrials.gov →
Summary
This is a retrospective, multi-center observational study to assess real-world outcomes of StimLabs human placental membrane tissue used in the treatment of hard-to-heal wounds, including chronic ulcers, diabetic foot ulcers (DFUs), and venous leg ulcers (VLUs). The collection of retrospective real-world data provides a broad range of experiences related to patient healthcare and treatment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-10-08.
Status change: Active, Not Recruiting → Completed 2026-06-04
Trial Details
NCT Number NCT07215741
Lead Sponsor StimLabs
Conditions Chronic Wounds, Diabetic Ulcers
Enrollment 23 participants
Start Date 2025-09-01
Primary Completion 2025-11-01 (estimated)
Study Completion 2025-11-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-30